In contrast to Samd14, which increases upon PHZ-induced anemia, Capzb and Capza2 mRNA and protein decreased after PHZ treatment in a population containing erythroid precursors (defined by surface markers CD71+Kit+Ter119-) (Figure 3B and Figure 3—figure supplement 1A and B). The gene discussed is CAPZA2; the disease is anemia.